Carbohydrate substrates in the gastrointestinal tract

Carbohydrate substrates in the gastrointestinal tract encompass a broad range of dietary molecules, including simple sugars, starches, and non-digestible fibers. These molecules serve as the primary energy source for human metabolism and play a vital role in modulating the gut microbiome through fermentation processes (Slavin, 2013). While not considered classical therapeutic targets such as receptors or enzymes, they are the central focus of pharmacological strategies aimed at managing metabolic diseases. For example, alpha-glucosidase inhibitors like acarbose function by preventing the enzymatic breakdown of these substrates into absorbable monosaccharides, thereby mitigating postprandial hyperglycemia in diabetic patients (StatPearls, 2023). Furthermore, the malabsorption or rapid fermentation of specific carbohydrate substrates, such as FODMAPs, is a significant factor in the clinical presentation of irritable bowel syndrome (Monash University, 2024). Consequently, therapeutic interventions often target the enzymes and transporters associated with these substrates rather than the carbohydrates themselves. Understanding the interaction between these substrates and the digestive system is crucial for developing dietary and pharmacological interventions for obesity and malabsorption (NIH, 2023).

Other names

Dietary carbohydratesGI carbohydratesIntestinal saccharidesDigestible and non-digestible carbohydrates

Inhibition of alpha-glucosidase enzymes to prevent the hydrolysis of oligosaccharides and disaccharides into monosaccharides; osmotic retention of water in the intestinal lumen; fermentation by colonic bacteria into short-chain fatty acids.